Bupropion attenuates methamphetamine self-administration in adult male rats

Drug and Alcohol Dependence

Volumn 100, Issue 1-2, 2009, Pages 54-62

  Reichel, Carmela M ^a   Murray, Jennifer E ^a   Grant, Kathleen M ^b   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Reinforcement; Stimulant; Substance use disorder; Wellbutrin; Zyban

Indexed keywords

AMFEBUTAMONE; METHAMPHETAMINE; SUCROSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; STEREOTYPY; SUBSTANCE ABUSE;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; BEHAVIOR, ADDICTIVE; BUPROPION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION;

RATTUS;

EID: 57649096277     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.09.006     Document Type: Article

References (51)

1. Beninger R.J., Cheng M., Hahn B.L., Hoffman D.C., Mazurski E.J., Morency M.A., Ramm P., and Stewart R.J. Effects of extinction, pimozide, SCH23390, and metoclopramide on food-rewarded operant responding of rats. Psychopharmacology 92 (1987) 343-349
2. Bhattacharyya A.K., and Pradhan S.N. Interactions between motor activity and stereotypy in cocaine-treated rats. Psychopharmacology 63 (1979) 311-312
3. Bruijnzeel A.W., and Markou A. Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse 50 (2003) 20-28
4. Bungay V., Malchy L., Buxton J., Johnson J., Macpherson D., and Rosenfeld T. Life with jib: a snapshot study of street youth's use of crystal methamphetamine. Addict. Theor. Res. 14 (2006) 151-235
5. Cooper B.R., Hester T.J., and Maxwell R.A. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J. Pharmacol. Exp. Ther. 215 (1980) 127-134
6. Dews P.B. Studies on behavior. IV. Stimulant action of methamphetamine. J. Pharmacol. Exp. Ther. 122 (1958) 137-147
7. Dwoskin L.P., Rauhut A.S., King-Pospisil K.A., and Bardo M.T. Review of the pharmacology and clinical profile of bupropionropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 12 (2006) 178-207
8. Elkashef A.M., Rawson R.A., Anderson A.L., Li S., Holmes T., Smith E.V., Chiang N., Kahn R., Vocci F., Ling W., Pearce V.J., McCann M., Campbell J., Gorodetzky C., Haning W., Carlton B., Mawhinney J., and Weis D. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33 (2008) 1162-1170
9. Gadde K.M., Parker C.B., Maner L.G., Wagner II H.R., Loque E.J., Drezner M.K., and Krishnan K.R. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes. Res. 9 (2001) 544-551
10. Gorelick D.A., Gardner E.L., and Xi Z.X. Agents in development for the management of cocaine abuse. Drugs 64 (2004) 1547-1573
11. Grabowski J., Shearer J., Merrill J., and Negus S. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict. Behav. 29 (2004) 1439-1464
12. Hiranita T., Nawata Y., Sakimura K., Anggadiredja K., and Yamamoto T. Suppression of methamphetamine-seeking behavior by nicotinic agonists. Proc. Natl. Acad. Sci. 103 (2006) 8523-8527
13. Ikemoto S., and Panksepp J. Dissociations between appetitive and consummatory responses by pharmacological manipulation of reward-relevant brain regions. Behav. Neurosci. 110 (1996) 331-345
14. Johnston L.D., Beninger R.J., and Olmstead M.C. Pimozide, like extinction, devalues stimuli associated with sucrose taking. Pharmacol. Biochem. Behav. 68 (2001) 583-590
15. Kim S., Westphalen R., Callahan B., Hatzidimitriou G., Yuan J., and Ricaurte G.A. Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J. Pharmacol. Exp. Ther. 293 (2000) 625-633
16. Kuczenski R., and Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9 (1989) 2051-2065
17. Kuczenski R., Segal D., Cho A., and Melega W. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J. Neurosci. 15 (1995) 1308-1317
18. Lile J.A. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. J. Exp. Clin. Pharmacol. 14 (2006) 20-33
19. Ling W., Rawson R., Shoptaw S., and Ling W. Management of methamphetamine abuse and dependence. Curr. Psychiatry Rep. 8 (2006) 345-354
20. Marek G.J., Vosmer G., and Seiden L.S. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513 (1990) 274-279
21. Melega W., Williams A., Schmitz D., DiStefano E., and Cho A. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. J. Pharmacol. Exp. Ther. 274 (1995) 90-96
22. Muley M.P., Joshi M.A., and Manekar M.S. Effect of bupropion on dopamine and 5-hydroxytryptamine-mediated behavior in mice. J. Pharm. Pharmacol. 36 (1984) 208-210
23. Munzar P., Baumann M.H., Shoaib M., and Goldberg S.R. Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology 141 (1999) 287-296
24. Munzar P., and Goldberg S. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology 148 (2000) 209-217
25. Nadal R., Chappell A.M., and Samson H.H. Effects of nicotine and mecamylamine microinjections into the nucleus accumbens on ethanol and sucrose self-administration. Alcohol Clin. Exp. Res. 22 (1998) 1190-1198
26. National Research Council, 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC.
27. Neugebauer N.M., Harrod S.B., Stairs D.J., Crooks P.A., Dwoskin L.P., and Bardo M.T. Lobelane decreases methamphetamine self-administration in rats. Euro. J. Pharmacol. 571 (2007) 33-38
28. Newton T.F., Roache J.D., De La Garza II R., Fong T., Wallace C.L., Li S.H., Elkashef A., Chiang N., and Kahn R. Safety of intravenous methamphetamine administration during treatment with bupropion. Psychopharmacology 182 (2005) 426-435
29. Newton T.F., Roache J.D., De La Garza II R., Fong T., Wallace C.L., Li S.H., Elkashef A., Chiang N., and Kahn R. Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31 (2006) 1537-1544
30. NIDA Research Report Series, 2006. Methamphetamine Abuse and Addiction. NIH Publication number 06-4210.
31. Nielsen J.A., Shannon N.J., Bero L., and Moore K.E. Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacol. Biochem. Behav. 24 (1986) 795-799
32. Nomikos G.G., Damsma G., Wenkstern D., and Fibiger H.C. Acute effects of bupropion on extracellular dopamine concentration in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 7 (1989) 7-14
33. Nomikos G.G., Damsma G., Wenkstern D., and Fibiger H.C. Effects of chronic bupropion on interstitial concentrations of dopamine in rat nucleus accumbens and striatum. Neuropsychopharmacology 7 (1992) 7-14
34. Paterson N.E., Semenova S., Gasparini F., and Markou A. The mGluR5 antagonist MPEP decreases nicotine self-administration in rats and mice. Psychopharmacology 167 (2003) 257-264
35. Pratt W.E., and Kelley A.E. Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behav. Neurosci. 118 (2004) 730-739
36. Rauhut A.S., Dwoskin L.P., and Bardo M.T. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Nicotine Tob. Res. 7 (2005) 901-907
37. Rauhut A.S., Neugebauer N., Dwoskin L.P., and Bardo M.T. Effect of bupropion on nicotine self-administration in rats. Psychopharmacology 169 (2003) 1-9
38. Reichel C.M., Linkugel J.D., and Bevins R.A. Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose maintained behavior. Pharmacol. Biochem. Behav. 89 (2008) 463-472
39. Reichel C.M., Wilkinson J.L., and Bevins R.A. Methamphetamine functions as a positive and negative drug feature in a Pavlovian appetitive discrimination task. Behav. Pharmacol. 18 (2007) 755-765
40. Robbins T.W., and Sahakian B.J. Paradoxical effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18 (1979) 931-950
41. Roll J.M. Contingency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 102 (2007) 114-120
42. Rothman R.B., Blough B.E., and Baumann M.H. Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann. N.Y. Acad. Sci. 965 (2002) 109-126
43. Rush C.R., Kollins S.H., and Pazzaglia P.J. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropionropion, and triazolam in d-amphetamine-trained humans. Exp. Clin. Psychopharmacol. 6 (1998) 32-44
44. Schoffelmeer A.M., De Vries T.J., Wardeh G., van de Ven H.W., and Vanderschuren L.J. Psycostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J. Neurosci. 22 (2002) 3269-3276
45. Slemmer J.E., Martin B.R., and Damaj M.E. Bupropion is a nicotinic antagonist. J. Pharmacol. Exp. Ther. 295 (2000) 321-327
46. Stairs D.J., and Dworkin S.I. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats. Pharm. Biochem. Behav. 90 (2008) 701-711
47. Substance Abuse and Mental Health Services Administration, 2007. Results from the 2006 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293, Rockville, MD.
48. Vocci F.J., and Appel N.M. Approaches to the development of medications for the treatment of methamphetamine dependence. Addiction 102 (2007) 96-106
49. Watkins S.S., Epping-Jordon M.P., Koob G.F., and Markou A. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol. Biochem. Behav. 62 (1999) 743-751
50. Wilkinson J.L., and Bevins R.A. Bupropion hydrochloride produces conditioned hyperactivity in rats. Physiol. Behav. 90 (2007) 790-796
51. Zarrindast M.R., and Hosseini-Nia T. Anorectic and behavioural effects of bupropion. Gen. Pharm. 19 (1988) 201-204